Reproductive System Neoplasm, Female - Cervical Cancer
NCT00803062
Clinical Trial Information
Trial Number: NCT00803062 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Cervical Cancer
Trial Title:
A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865) Versus the Non-platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
Study ID:
GOG-0240
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT01672892
Clinical Trial Information
Trial Number: NCT01672892 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Cervical Cancer
- Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Study ID:
RTOG-1203
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01672892-D1 | This dataset contains patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT01672892 to reproduce the results in PubMed ID=29989857. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®